Jen Smith

Jen Smith is the medical editor of Cancer Therapy Advisor. She was previously the editor of Hematology Times and the oncology editor for MDedge Hematology/Oncology. She has a BS in journalism.

All articles by Jen Smith

Masked doctor and patient talking to each other.

ESMO 2021

Brigatinib Continues to Best Crizotinib in ALK+ Non-Small Cell Lung Cancer

Jen Smith

September 17, 2021

There was an improvement in progression-free survival despite crossover.

Pancreatic Cancer

Napabucasin Provides No Added Benefit in Metastatic Pancreatic Cancer

Jen Smith

September 17, 2021

The phase 3 CanStem111P study was terminated early due to futility.

ESMO 2021

Presence of ctDNA Predicts Worse Outcomes in Early Breast Cancer

Jen Smith

September 17, 2021

The presence of ctDNA, both at baseline and after treatment, was associated with worse survival outcomes.

ESMO 2021

Real-World Data Suggest Vaccination Reduces Risk of COVID-19 in Patients With Cancer

Jen Smith

September 17, 2021

Most vaccinated patients reported having mild side effects or none at all.

Next post in ESMO 2021

Jen Smith

All articles by Jen Smith

Brigatinib Continues to Best Crizotinib in ALK+ Non-Small Cell Lung Cancer

Napabucasin Provides No Added Benefit in Metastatic Pancreatic Cancer

Presence of ctDNA Predicts Worse Outcomes in Early Breast Cancer

Real-World Data Suggest Vaccination Reduces Risk of COVID-19 in Patients With Cancer

Long-Term COVID-19 Symptoms Linked to Treatment, Survival of Cancer Patients